8-K current report · filed Sep 10, 2026

Elevance Health (ELV) 8-K Current Report: September 10, 2026

Item 7.01ELV overview

Short answer

Elevance Health (ELV) filed an 8-K current report with the SEC on September 10, 2026 reporting Item 7.01 (Regulation FD Disclosure). Reaffirmed FY2026 shareholders’ earnings guidance of at least $20.10 per diluted share.

Elevance Health 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Reaffirmed FY2026 shareholders’ earnings guidance of at least $20.10 per diluted share
  • Adjusted FY2026 earnings guidance remains at least $27.00 per diluted share, excluding approximately $6.90 of unfavorable items
  • Reaffirmed FY2026 benefit expense ratio guidance of 90.2%, plus or minus 50 basis points
  • Guidance stability supports near-term earnings visibility, while benefit-cost performance remains the key operating sensitivity

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Elevance Health 8-K filings

Get the next ELV 8-K as it lands

Follow ELV for push alerts, or ask the research agent what this filing means.